L7|ESP® for the Pharma Industry

reducing the cost and time to market of pharmaceuticals

For pharma companies that are involved in small molecule, biologics, cell & gene, and other advanced therapies, L7|ESP provides an integrated data and process platform, which enables bringing drugs to market faster and reducing operational costs.

The pharmaceutical industry is at the forefront of developing novel treatments for a variety of complex diseases and medical conditions. In recent years, there has been increasing interest in developing advanced therapeutics such as cell and gene therapies, which offer the potential for more targeted and personalized treatments. Advanced therapeutics require complex data management and analysis, from preclinical research to clinical trials, in order to bring new treatments to market.

L7|ESP’s platform is designed to support the development of advanced therapeutics, such as cell and gene therapies. The platform’s robust data management and analytics capabilities make it easier to manage the complex data associated with these novel therapies, from preclinical research to clinical trials. L7|ESP also provides automated workflows and data pipelines, which can be customized to meet the specific needs of each individual study. By automating these processes, researchers can save valuable time and focus on more complex analyses and experimental designs.